Activity
-
Today, Akero announced the initiation of SYNCHRONY Outcomes, the third study in our Phase 3 SYNCHRONY trial program. We are actively recruiting…
Today, Akero announced the initiation of SYNCHRONY Outcomes, the third study in our Phase 3 SYNCHRONY trial program. We are actively recruiting…
Liked by Aaron Kantoff
-
Read full release here: https://lnkd.in/eA8uYK-C
Read full release here: https://lnkd.in/eA8uYK-C
Liked by Aaron Kantoff
-
BIOTECH NEWS: Tourmaline Bio has initiated the clinical development of TOUR006 for the treatment of cardiovascular diseases with the first patient…
BIOTECH NEWS: Tourmaline Bio has initiated the clinical development of TOUR006 for the treatment of cardiovascular diseases with the first patient…
Liked by Aaron Kantoff
Experience & Education
Volunteer Experience
More activity by Aaron
-
Centessa was proud to sponsor the recent Wake Up Narcolepsy National Summit. This tremendous event allowed members of our team (Deborah Hartman…
Centessa was proud to sponsor the recent Wake Up Narcolepsy National Summit. This tremendous event allowed members of our team (Deborah Hartman…
Liked by Aaron Kantoff
-
Akero is pleased to announce the appointment of CMC veteran Scott Gangloff as #ChiefTechnologyOfficer. With nearly 30 years of industry experience…
Akero is pleased to announce the appointment of CMC veteran Scott Gangloff as #ChiefTechnologyOfficer. With nearly 30 years of industry experience…
Liked by Aaron Kantoff
-
Today we, along with the entire MASH community, celebrate the FDA approval of REZDIFFRA. MASH represents a substantial and growing health concern for…
Today we, along with the entire MASH community, celebrate the FDA approval of REZDIFFRA. MASH represents a substantial and growing health concern for…
Liked by Aaron Kantoff
-
As of today, RayzeBio, Inc. is officially part of Bristol Myers Squibb! We are excited to continue our mission and look forward to delivering…
As of today, RayzeBio, Inc. is officially part of Bristol Myers Squibb! We are excited to continue our mission and look forward to delivering…
Liked by Aaron Kantoff
-
Glad that Nona partner network is expanding rapidly. Grow together with our partners! Congrats Aaron Kantoff ! Look forward to building companies…
Glad that Nona partner network is expanding rapidly. Grow together with our partners! Congrats Aaron Kantoff ! Look forward to building companies…
Liked by Aaron Kantoff
-
Korro Bio, Inc. is pioneering RNA editing to rewrite the future of medicine. 🧬 Joining us for the Nasdaq Closing Bell, $KRRO is a biopharmaceutical…
Korro Bio, Inc. is pioneering RNA editing to rewrite the future of medicine. 🧬 Joining us for the Nasdaq Closing Bell, $KRRO is a biopharmaceutical…
Liked by Aaron Kantoff
-
Exciting times for the Scion team!! https://lnkd.in/egC3ZRpf
Exciting times for the Scion team!! https://lnkd.in/egC3ZRpf
Liked by Aaron Kantoff
-
Excited to officially announce the oversubscribed $310M close of Scion Life Sciences Fund I. Thank you to all our terrific LPs and partners who…
Excited to officially announce the oversubscribed $310M close of Scion Life Sciences Fund I. Thank you to all our terrific LPs and partners who…
Liked by Aaron Kantoff
-
Excited to announce the inaugural 2024 Global Takeoff Summit on May 16th in New York City at The Company Building. The Takeoff Summit is an…
Excited to announce the inaugural 2024 Global Takeoff Summit on May 16th in New York City at The Company Building. The Takeoff Summit is an…
Liked by Aaron Kantoff
-
We are pleased to have closed today on our follow-on offering of common stock, totaling $172.5 million of gross proceeds to the company. We are…
We are pleased to have closed today on our follow-on offering of common stock, totaling $172.5 million of gross proceeds to the company. We are…
Liked by Aaron Kantoff
-
My son Jasper (16) and I climbed Mount Kilimanjaro, Africa's highest peak and watched the dawn of 2024 from the top. At times it was exhausting…
My son Jasper (16) and I climbed Mount Kilimanjaro, Africa's highest peak and watched the dawn of 2024 from the top. At times it was exhausting…
Liked by Aaron Kantoff
People also viewed
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More